Bodycote plc (LON:BOY - Get Free Report) shares passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 635.61 ($7.82) and traded as high as GBX 640 ($7.87). Bodycote shares last traded at GBX 633.22 ($7.79), with a volume of 620,583 shares trading hands.
Analyst Ratings Changes
Separately, Berenberg Bank restated a "buy" rating and set a GBX 800 ($9.84) price objective on shares of Bodycote in a report on Friday, December 13th.
Get Our Latest Analysis on BOY
Bodycote Stock Performance
The company's fifty day moving average price is GBX 615.57 and its two-hundred day moving average price is GBX 635. The company has a debt-to-equity ratio of 20.80, a quick ratio of 0.74 and a current ratio of 0.81. The firm has a market capitalization of £1.15 billion, a PE ratio of 1,900.00, a price-to-earnings-growth ratio of 1.44 and a beta of 1.18.
Insider Buying and Selling
In other news, insider Daniel A. Dayan purchased 36,000 shares of the stock in a transaction on Friday, October 25th. The stock was purchased at an average price of GBX 547 ($6.73) per share, with a total value of £196,920 ($242,303.43). 2.32% of the stock is currently owned by company insiders.
About Bodycote
(
Get Free Report)
The leading provider of heat treatment and specialist thermal processing services worldwide.
Heat treatment encompasses a variety of techniques and specialist engineering processes which improve the properties of metals and alloys and extend the life of components and is a vital part of any manufacturing process.
Bodycote is uniquely placed via our global network and the experience and knowledge of our people to offer high quality, reliable and cost-effective services to manufacturers whatever their size or market sector.
Further Reading
Before you consider Bodycote, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bodycote wasn't on the list.
While Bodycote currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
